COVID-19 Booster Study In Immunocompromised Patients Gives Novavax Another Shot On Goal

Manufacturing Issues Have Delayed Filing

 
• By Andrew McConaghie
  
Novavax
Novavax has seen its regulatory filings delayed by manufacturing supply and quality issues, but finally looks set to gain its first authorizations later this year.

More from Business

More from Scrip